Cargando…

Antimicrobial stewardship programs and convalescent plasma for COVID-19: A new paradigm for preauthorization?

Detalles Bibliográficos
Autores principales:	Stevens, Michael P., Patel, Payal K., Nori, Priya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7588712/ https://www.ncbi.nlm.nih.gov/pubmed/32900407 http://dx.doi.org/10.1017/ice.2020.459

Ejemplares similares

Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck
por: Stevens, Michael P., et al.
Publicado: (2020)

Rational allocation of coronavirus disease 2019 (COVID-19) vaccines to healthcare personnel and patients: A role for antimicrobial stewardship programs?
por: Nori, Priya, et al.
Publicado: (2020)

Antimicrobial Stewardship at the Core of COVID-19 Response Efforts: Implications for Sustaining and Building Programs
por: Mazdeyasna, Hasti, et al.
Publicado: (2020)

Rising from the pandemic ashes: Reflections on burnout and resiliency from the infection prevention and antimicrobial stewardship workforce
por: Nori, Priya, et al.
Publicado: (2022)

Preauthorization Inconsistencies Prevail in Reduction Mammaplasty
por: Boyd, Carter J., et al.
Publicado: (2023)

Practical implementation of COVID-19 patient flags into an antimicrobial stewardship program’s prospective review
por: Stevens, Ryan W., et al.
Publicado: (2020)

The effect of the preauthorization system on oral antimicrobials at a maternal and children’s hospital in Japan
por: Kinoshita, Noriko, et al.
Publicado: (2017)

Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic: a Window of Opportunity
por: Assi, Mariam, et al.
Publicado: (2021)

The impact of an antimicrobial stewardship program restriction on remdesivir prescribing
por: Zeitler, Kristen E., et al.
Publicado: (2022)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Assessment of preauthorization and 24-hour expert consultation as a restrictive antimicrobial stewardship bundle in a Brazilian tertiary-care hospital: an interrupted time series analysis
por: Doltrario, Andréa Beltrami, et al.
Publicado: (2022)

Convalescent plasma in the management of COVID-19 pneumonia
por: Elbadawi, Ayman, et al.
Publicado: (2021)

How Safe Is COVID-19 Convalescent Plasma?
por: Franchini, Massimo, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy and immunodeficiency
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Antimicrobial usage and the pediatrics population: a need for the implementation of antimicrobial stewardship programs in Turkey
por: Khan, Zakir, et al.
Publicado: (2021)

Pediatric antimicrobial stewardship in the COVID-19 outbreak
por: Velasco-Arnaiz, Eneritz, et al.
Publicado: (2020)

COVID-19 and antimicrobial stewardship: What is the interplay?
por: Spernovasilis, Nikolaos A., et al.
Publicado: (2020)

Antimicrobial stewardship program prompts increased and earlier infectious diseases consultation
por: Morrill, Haley J, et al.
Publicado: (2014)

‘Treatment of COVID-19 with convalescent plasma’ – Author’s reply
por: Wooding, Denise J., et al.
Publicado: (2021)

Use of convalescent plasma in COVID-19 patients in China
por: Zhu, M., et al.
Publicado: (2020)

Convalescent plasma (CP) therapy in patients with COVID-19
por: Cakir, Banu
Publicado: (2021)

In Reply—How Safe Is COVID-19 Convalescent Plasma?
por: Joyner, Michael J., et al.
Publicado: (2021)

Surgical Antimicrobial Prophylaxis and Adherence to Standard Treatment Guidelines: Urgent Need of Antimicrobial Stewardship Program
por: Khan, Zakir, et al.
Publicado: (2019)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Convalescent plasma to treat COVID-19: Its challenges in Iraq's situation
por: Hashim, H.T.
Publicado: (2020)

Challenges in the production of COVID-19 convalescent plasma- analysis of donor recruitment
por: Sekiya, Eliseo Joji, et al.
Publicado: (2021)

High-Dose Convalescent Plasma for Treatment of Severe COVID-19 (response)
por: De Santis, Gil C., et al.
Publicado: (2022)

COVID-19 vaccination: The impact on the selection criteria of the convalescent plasma donors
por: Bansal, N., et al.
Publicado: (2021)

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality
por: Paneth, Nigel, et al.
Publicado: (2023)

The true historical origin of convalescent plasma therapy
por: Marson, Piero, et al.
Publicado: (2020)

Antimicrobial stewardship without infectious disease physician
por: Komagamine, Junpei
Publicado: (2018)

The case for curriculum development in antimicrobial stewardship interventions
por: Keller, Sara C., et al.
Publicado: (2022)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Early and persistent viral clearance in COVID-19 patients treated with convalescent plasma
por: Franchini, Massimo, et al.
Publicado: (2021)

Neutralizing Autoantibodies to Type I Interferons in COVID-19 Convalescent Donor Plasma
por: Vazquez, Sara E., et al.
Publicado: (2021)

Covid-19 convalescent plasma and SARS-CoV-2 viral variants
por: Joob, B., et al.
Publicado: (2021)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma: A possible treatment of COVID-19 in India
por: Teixeira da Silva, Jaime A.
Publicado: (2020)

Severe COVID-19 in Patients with B Cell Alymphocytosis and Response to Convalescent Plasma Therapy
por: London, Jonathan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vstr2oj7phh135quikl8l45b1r